HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MT-7716, a potent NOP receptor agonist, preferentially reduces ethanol seeking and reinforcement in post-dependent rats.

Abstract
Dysregulation of the nociceptin (N/OFQ) system has been implicated in alcohol abuse and alcoholism, and growing evidence suggests that targeting this system may be beneficial for treating alcoholism. To further explore the treatment target potential of the N/OFQ system, the novel non-peptide, small-molecule N/OFQ (NOP) agonist MT-7716, (R)-2-{3-[1-(Acenaphthen-1-yl)piperidin-4-yl]-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl}-N-methylacetamide hydrochloride hydrate, was examined for its effects on ethanol self-administration and stress-induced reinstatement of alcohol seeking in non-dependent and post-dependent rats. Male Wistar rats were trained to self-administer ethanol and then made ethanol dependent via repeated intragastric ethanol intubation. The effects of MT-7716 (0.3 and 1 mg/kg; PO) on alcohol self-administration were determined 2 weeks following dependence induction, when baseline self-administration was restored. Effects of MT-7716 on stress-induced reinstatement were tested in separate cohorts of rats, 1 and 3 weeks post-withdrawal. MT-7716 reduced alcohol self-administration and stress-induced reinstatement of alcohol seeking in post-dependent rats, but was ineffective in non-dependent animals. Moreover, the prevention of stress-induced reinstatement by MT-7716 was more pronounced at 3 weeks post-dependence. The results further confirm treatment target potential for the NOP receptor and identify non-peptide NOP agonists as promising potential treatment drugs for alcohol abuse and relapse prevention. The findings also support dysregulation of the N/OFQ system as a factor in alcohol seeking and reinforcement.
AuthorsGiordano de Guglielmo, Rémi Martin-Fardon, Koji Teshima, Roberto Ciccocioppo, Friedbert Weiss
JournalAddiction biology (Addict Biol) Vol. 20 Issue 4 Pg. 643-51 (Jul 2015) ISSN: 1369-1600 [Electronic] United States
PMID24930632 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2014 Society for the Study of Addiction.
Chemical References
  • 2-(3-(1-(acenaphthen-1-yl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)-N-methylacetamide
  • Acenaphthenes
  • Benzimidazoles
  • Narcotic Antagonists
  • Opioid Peptides
  • Receptors, Opioid
  • Ethanol
  • nociceptin
  • Nociceptin Receptor
  • Oprl protein, rat
Topics
  • Acenaphthenes (pharmacology)
  • Alcoholism (blood, prevention & control)
  • Analysis of Variance
  • Animals
  • Benzimidazoles (pharmacology)
  • Conditioning, Operant
  • Drug-Seeking Behavior (drug effects)
  • Ethanol (metabolism)
  • Male
  • Narcotic Antagonists (pharmacology)
  • Nociception (drug effects)
  • Opioid Peptides (antagonists & inhibitors)
  • Rats, Wistar
  • Receptors, Opioid (drug effects)
  • Reinforcement, Psychology
  • Self Administration
  • Stress, Psychological (psychology)
  • Nociceptin Receptor

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: